Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Januar 2025

NOVO — Januar 2025

Planlagt Fastgjort Låst Flyttet NOVO
233 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Scvej
    wrote on sidst redigeret af
    #123

    Men sikke da hvor de dårlige nyheder fortsætter med og vælte ind over Danmark.. Trumps tariffer, Grønland, og nu skal Novos priser på sema sjovt nok lige forhandles i usa.. man skulle næsten tro det hang sammen 🙂

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Scvej
      wrote on sidst redigeret af
      #124

      Det er med og holde fast i bordkanten for tiden, og så huske og tage et ekstra glas om aftenen, det går jo nok alt sammen 🙂

      1 Reply Last reply
      0
      • L Offline
        L Offline
        lahn1
        wrote on sidst redigeret af
        #125

        I den forrige runde med 10 drugs, siges The White House has stated that these new prices will cut the list prices of these drugs between 38% and 79%. Januvia måtte give 79% rabat og Eliquis som mange kender måtte give 56% rabat til Medicare.

        1 Reply Last reply
        0
        • L Offline
          L Offline
          lahn1
          wrote on sidst redigeret af
          #126

          Håber Novo og de andre drug makers står fast på at PBM skal afskaffes.

          1 Reply Last reply
          0
          • S Offline
            S Offline
            Scvej
            wrote on sidst redigeret af
            #127

            Jeg syntes fruergaard forsvarede Novo ret godt i sin senatshøring om netop priserne sidste år. Og det største problem ER jo PBM, hvordan det virksomhedslag kan få lov og drive forretning på den måde er vanvittigt

            1 Reply Last reply
            0
            • L Offline
              L Offline
              lahn1
              wrote on sidst redigeret af
              #128

              Helt ening. Trump og hans kabinet MÅ da kunne se det er dårligt for økonomien med det ekstra led. Krydser fingre for at Novo kommer helskindet igennem processen.

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JKY_VH
                wrote on sidst redigeret af
                #129

                Ja Scvej, det har han i hvert fald tidligere sagt at han vil "Mellemmændene, de såkaldte PBM’er, skal ud af ligningen, lyder det fra USA’s kommende præsident."

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  Bjæssing09
                  wrote on sidst redigeret af
                  #130

                  Man skal sidde på hænderne her og supplere, hvis man har lidt på kistebunden. Novo skal nok rejse sig igen........

                  1 Reply Last reply
                  0
                  • S Offline
                    S Offline
                    Stockwatch1
                    wrote on sidst redigeret af
                    #131

                    UBS:
                    Discontinuations in STEP UP were lower than in STEP 1 according to our conversations
                    with the company, which indicates that tolerability was reasonable. The study allowed
                    for some flexibility in dosing, but not to the extent of the REDEFINE dosing regimens (the
                    company state the STEP UP is more similar to the original STEP dosing regimens than vs
                    REDEFINE)

                    1 Reply Last reply
                    0
                    • S Offline
                      S Offline
                      Stockwatch1
                      wrote on sidst redigeret af
                      #132

                      In terms of % of patients that finished on the top dose, Novo state that it
                      was lower for 7.2mg vs 2.4mg but have not provided numbers

                      1 Reply Last reply
                      0
                      • S Offline
                        S Offline
                        Stockwatch1
                        wrote on sidst redigeret af
                        #133

                        Pushback from the results is that this step up in efficacy for sema reduces the need for
                        CagriSema and does not extend the semaglutide patent cliff. We still see CagriSema as
                        another step ahead of efficacy, with REDEFINE-1 providing 2% additional weight loss
                        despite the more flexible dosing regimens and could provide further differentiation in
                        type-2 diabetics and comorbidities.

                        1 Reply Last reply
                        0
                        • S Offline
                          S Offline
                          Stockwatch1
                          wrote on sidst redigeret af
                          #134

                          We
                          see the results as providing a boost for the longer term Wegovy franchise, albeit does
                          not extend patent life. We expect any decision on filing and launch to take account of
                          the supply situation, but we would expect any regulatory review to be only c.6 months
                          given it is a supplemental dosage and not a new indication.

                          1 Reply Last reply
                          0
                          • S Offline
                            S Offline
                            Stockwatch1
                            wrote on sidst redigeret af
                            #135

                            UBS' kommentarer til dagens data, netop udsendt

                            1 Reply Last reply
                            0
                            • J Offline
                              J Offline
                              JKY_VH
                              wrote on sidst redigeret af
                              #136

                              tak Sw

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                koden
                                wrote on sidst redigeret af
                                #137

                                Da de mest pessimistiske analytikere satte kursmål 5xx tilbage i sommers, da tænkte jeg de havde fis i kasketten. Men må sige de fik ret.

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  ProinvestorNEWS
                                  wrote on sidst redigeret af
                                  #138

                                  Novo er ramt af usikkerhed vurderer Sydbank: Prisforhandlinger bør ikke overraske https://proinvestor.com/investornyt/1266560/novo-er-ramt-af-usikkerhed-vurderer-sydbank-prisforhandlinger-bor-ikke-overraske

                                  1 Reply Last reply
                                  0
                                  • P Offline
                                    P Offline
                                    ProinvestorNEWS
                                    wrote on sidst redigeret af
                                    #139

                                    Video - Novo Nordisk aktieanalyse! Købsmulighed? https://proinvestor.com/boards/124284

                                    1 Reply Last reply
                                    0
                                    • H Offline
                                      H Offline
                                      Hansen
                                      wrote on sidst redigeret af
                                      #140

                                      Fra bioSpace https://www.biospace.com/drug-development/novo-nordisk-links-high-dose-wegovy-to-increased-weight-loss-in-phase-iii-trial?_gl=1*1t5e3kc*_up*MQ.._gaMTQ4OTIxMjQ1Ni4xNzM3MjcwOTI2*_ga_Q90M6MWJZ4*MTczNzI3MDkyNC4xLjAuMTczNzI3MTExNi4wLjAuMA..

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        ProinvestorNEWS
                                        wrote on sidst redigeret af
                                        #141

                                        Novo Nordisk: Det halvfyldte glas er blevet halvt tomt https://proinvestor.com/boards/124293

                                        1 Reply Last reply
                                        0
                                        • J Offline
                                          J Offline
                                          JKY_VH
                                          wrote on sidst redigeret af
                                          #142

                                          Nordea gentager køb og kursmål 977 We reiterate Buy with an unchanged DCF-derived target of DKK 977 per share

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper